In thyroid carcinoma, eIF6 promotes tumor growth by regulating MIR-144-3p/TGF-α, and the knockout of eIF6 enhances cisplatin sensitivity [20]. This evidence concerns the gene EIF6 and thyroid gland carcinoma.